CN101549002B - Tincture for curing flat wart and method for preparing the same - Google Patents
Tincture for curing flat wart and method for preparing the same Download PDFInfo
- Publication number
- CN101549002B CN101549002B CN2009100844767A CN200910084476A CN101549002B CN 101549002 B CN101549002 B CN 101549002B CN 2009100844767 A CN2009100844767 A CN 2009100844767A CN 200910084476 A CN200910084476 A CN 200910084476A CN 101549002 B CN101549002 B CN 101549002B
- Authority
- CN
- China
- Prior art keywords
- mass fraction
- tincture
- ethanol
- onset
- month
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A tincture for curing flat wart and method for preparing the same, constituents of the tincture include spotted caterpillar, safflower and alcohol containing 75% mass fraction ethanol, in the tincturethe mass fraction of the spotted caterpillar is 2-30%, mass fraction of the safflower is 10-80%, and mass fraction of the 75% mass fraction ethanol is 18-88%. The tincture has simple composition, eas y manufacture and low price, and the tincture can cure the flat wart completely.
Description
Technical field
The present invention relates to a kind of topical agent of treating verruca plana, particularly a kind of tincture and method for making thereof that is used to treat verruca plana.
Background technology
Verruca plana is a kind of viral dermatosis, because of it mainly invades teenager, so claim flat wart again.The traditional Chinese medical science is claimed " verruca plana ", and its pathogen is the same with verruca vulgaris, is to infect the skin vegetations that causes by papillomavirus HPV3 and HPV5.Show as that dispersed and distributed, quality are soft, the top is smooth, foxtail millet grain to Semen phaseoli radiati big, light brown or exceed the flat pimple of skin surface.Good sending out in exposure portion such as face, the back of the hand portions is the natural enemy of beauty treatment.Verruca plana is repugnant to the eye, embarrassing pigmentation, serious self-confidence of destroying the personage that likes to be beautiful; In addition, verruca plana also infects relatives and friends extremely easily, brings huge threat at one's side relatives' physical and mental health, and certain infectiousness is arranged, because disease time is long more, verruca plana forms serious pigmentation more easily, and brings out other serious consequence easily.
The method of existing treatment verruca plana all has a lot of defectives:
(1) oral medicine: owing to arrive skin from oral the absorption to internal organs, efficacy of a drug loss is big, is not direct kill virus, so effect is unsatisfactory, and will take continuously for a long time tens days, and common people are difficult to adhere to.
(2) injection hormone transfer factor: the western medical treatment verruca plana is mainly injected hormone such as transfer factor and is improved the human body function of exempting from service.Because this a kind of indirect treatment is not directly can kill verruca plana virus, so cure rate is also very low, particularly to higher people of some ages.
(3) external-applied ointment: tretinoin emulsifiable paste, peptide butylamine ointment etc. contains the hormones composition, permanent use quite big to human harm, suggestion need not, perhaps use less.
(4) method that adopts laser to root out: because verruca plana virus is in the below the epidermis; Laser can only be rooted out surperficial verruca plana granule; And subcutaneous virus is not rooted out, so can not play basic therapeutical effect, has often crossed the some months verruca plana and also can send again.
Summary of the invention
It is simple that the object of the invention just provides a kind of prescription, makes easily, the Chinese medicine tincture and the method for making thereof of cheap and radical cure verruca plana.
The technical scheme that the present invention is adopted for its technical problem of solution is: it is 75% ethanol that a kind of tincture of treating verruca plana, the constituent of this tincture comprise Mylabris, Flos Carthami and ethanol mass fraction.The mass fraction of the Mylabris in this tincture is 2-30%, and the mass fraction of Flos Carthami is 10%-80%, and the ethanol mass fraction is that the mass fraction of 75% ethanol is 18-88%.
A kind of manufacturing approach of treating the tincture of verruca plana, this tincture are to be 75% alcohol-pickled making with Mylabris, Flos Carthami and ethanol mass fraction.The mass fraction of making the Mylabris in this tincture is 2-30%, and the mass fraction of Flos Carthami is 10%-80%, and the ethanol mass fraction is that the mass fraction of 75% ethanol is 18-88%.
The beneficial effect that the present invention adopts technique scheme to reach is:
Prescription of the present invention is simple, is prone to produce, and cost is low, and can improve symptom fast, the radical cure verruca plana, and clinical result of use is as shown in the table:
| The male patient | Female patient | Amount to | Account for total number of persons percentage ratio | |
| The clinical treatment number | 111 | 46 | 157 | |
| 7 with interior onset | 18 | 10 | 28 | 17.8％ |
| 7-14 day onset | 68 | 23 | 91 | 58.0％ |
| 14-21 day onset | 18 | 9 | 27 | 17.2％ |
| Onset more than 21 days | 7 | 4 | 11 | 7.0％ |
| 1 month with interior healing | 21 | 6 | 27 | 17.2％ |
| Cured in 1-2 month | 70 | 29 | 99 | 63.1％ |
| Cure more than 2 months | 20 | 11 | 31 | 19.7％ |
| Invalid fully | 0 | 0 | 0 | 0％ |
The specific embodiment
The invention discloses a kind of tincture of treating verruca plana; It is 75% ethanol that the constituent of this tincture comprises Mylabris and Flos Carthami and ethanol mass fraction; In particular; The mass fraction of the Mylabris in this tincture is 2-30%, and the mass fraction of Flos Carthami is 10%-80%, and the ethanol mass fraction is that the mass fraction of 75% ethanol is 18-88%.
The invention also discloses the manufacturing approach of above-mentioned tincture; It is that Mylabris and Flos Carthami are used the ethanol mass fraction is 75% alcohol-pickled making; The mass fraction of making the Mylabris in this tincture is 2-30%; The mass fraction of Flos Carthami is 10%-80%, and the ethanol mass fraction is that the mass fraction of 75% ethanol is 18-88%.
Embodiment 1
This tincture is got 2 gram Mylabris, 15 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 83 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 14 | 5 | 19 |
| 7 with interior onset | 0 | 0 | 0 |
| 7-14 day onset | 12 | 4 | 16 |
| 14-21 day onset | 2 | 1 | 3 |
| Onset more than 21 days | 0 | 0 | 0 |
| 1 month with interior healing | 3 | 1 | 4 |
| Cured in 1-2 month | 10 | 4 | 14 |
| Cure more than 2 months | 1 | 0 | 1 |
| Invalid fully | 0 | 0 | 0 |
Embodiment 2
This tincture is got 15 gram Mylabris, 18 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 67 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 8 | 7 | 15 |
| 7 with interior onset | 0 | 1 | 1 |
| 7-14 day onset | 7 | 4 | 11 |
| 14-21 day onset | 1 | 1 | 2 |
| Onset more than 21 days | 0 | 1 | 1 |
| 1 month with interior healing | 2 | 1 | 3 |
| Cured in 1-2 month | 6 | 4 | 10 |
| Cure more than 2 months | 0 | 2 | 2 |
| Invalid fully | 0 | 0 | 0 |
Embodiment 3
This tincture is got 30 gram Mylabris, 20 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 50 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 22 | 6 | 28 |
| 7 with interior onset | 7 | 3 | 10 |
| 7-14 day onset | 10 | 2 | 12 |
| 14-21 day onset | 3 | 1 | 4 |
| Onset more than 21 days | 2 | 0 | 2 |
| 1 month with interior healing | 5 | 1 | 6 |
| Cured in 1-2 month | 16 | 4 | 20 |
| Cure more than 2 months | 1 | 1 | 2 |
| Invalid fully | 0 | 0 | 0 |
Embodiment 4
This tincture is got 12 gram Mylabris, 45 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 43 grams is to be worth in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 11 | 6 | 17 |
| 7 with interior onset | 5 | 3 | 8 |
| 7-14 day onset | 6 | 3 | 9 |
| 14-21 day onset | 0 | 0 | 0 |
| Onset more than 21 days | 0 | 0 | 0 |
| 1 month with interior healing | 7 | 2 | 9 |
| Cured in 1-2 month | 3 | 4 | 7 |
| Cure more than 2 months | 1 | 0 | 1 |
| Invalid fully | 0 | 0 | 0 |
Embodiment 5
This tincture is got 4 gram Mylabris, 60 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 28 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 10 | 5 | 15 |
| 7 with interior onset | 1 | 1 | 2 |
| 7-14 day onset | 9 | 3 | 12 |
| 14-21 day onset | 0 | 1 | 1 |
| Onset more than 21 days | ?0 | 0 | 0 |
| 1 month with interior healing | ?1 | 1 | 2 |
| Cured in 1-2 month | ?8 | 3 | 11 |
| Cure more than 2 months | ?1 | 1 | 2 |
| Invalid fully | ?0 | 0 | 0 |
Embodiment 6
This tincture is got 2 gram Mylabris, 80 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 18 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 7 | 5 | 12 |
| 7 with interior onset | 0 | 0 | 0 |
| 7-14 day onset | 2 | 1 | 3 |
| 14-21 day onset | 3 | 3 | 6 |
| Onset more than 21 days | 2 | 1 | 3 |
| 1 month with interior healing | 0 | 0 | 0 |
| Cured in 1-2 month | 1 | 1 | 2 |
| Cure more than 2 months | 6 | 4 | 10 |
| Invalid fully | 0 | 0 | 0 |
Embodiment 7
This tincture is got 20 gram Mylabris, 10 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 70 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 15 | 6 | 21 |
| 7 with interior onset | 3 | 1 | 4 |
| 7-14 day onset | 11 | 3 | 14 |
| 14-21 day onset | 1 | 1 | 2 |
| Onset more than 21 days | 0 | 1 | 1 |
| 1 month with interior healing | 2 | 0 | 2 |
| Cured in 1-2 month | 12 | 5 | 17 |
| Cure more than 2 months | 1 | 1 | 2 |
| Invalid fully | 0 | 0 | 0 |
Embodiment 8
This tincture is got 2 gram Mylabris, 50 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 48 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 14 | 3 | 17 |
| 7 with interior onset | 2 | 1 | 3 |
| 7-14 day onset | 10 | 2 | 12 |
| 14-21 day onset | 2 | 0 | 2 |
| Onset more than 21 days | 0 | 0 | 0 |
| 1 month with interior healing | 1 | 0 | 1 |
| Cured in 1-2 month | 13 | 3 | 16 |
| Cure more than 2 months | 1 | 0 | 1 |
| Invalid fully | 0 | 0 | 0 |
Embodiment 9
This tincture is got 2 gram Mylabris, 10 gram Flos Carthamis, and the ethanol mass fraction that is immersed in 88 grams is to make in 75% the ethanol.
Clinical therapeutic efficacy sees also following table
| The male patient | Female patient | Amount to | |
| The clinical treatment number | 10 | 3 | 13 |
| 7 with interior onset | 0 | 0 | 0 |
| 7-14 day onset | 1 | 1 | 2 |
| 14-21 day onset | 6 | 1 | 7 |
| Onset more than 21 days | 3 | 1 | 4 |
| 1 month with interior healing | 0 | 0 | 0 |
| Cured in 1-2 month | 1 | 1 | 2 |
| Cure more than 2 months | 9 | 2 | 11 |
| Invalid fully | 0 | 0 | 0 |
Above-mentioned case was not all collected any expense, and therapeutic effect feeds back to the inventor by the patient, all obtained special good effect, gathered like following table
Clinical result of use summary table
| The male patient | Female patient | Amount to | Account for total number of persons percentage ratio | |
| The clinical treatment number | 111 | 46 | 157 | |
| 7 with interior onset | 18 | 10 | 28 | 17.8％ |
| 7-14 day onset | 68 | 23 | 91 | 58.0％ |
| 14-21 day onset | 18 | 9 | 27 | 17.2％ |
| Onset more than 21 days | 7 | 4 | 11 | 7.0％ |
| 1 month with interior healing | 21 | 6 | 27 | 17.2％ |
| Cured in 1-2 month | 70 | 29 | 99 | 63.1％ |
| Cure more than 2 months | 20 | 11 | 31 | 19.7％ |
| Invalid fully | 0 | 0 | 0 | 0％ |
In use, tincture is spread upon the affected part, general 3-6 time on the one (can increase smear number of times like especially severe); Basically get final product onset (being that symptom is obviously alleviated) in day smearing 7-14; Can cure about continuous use 1-2 month, the symptom complete obiteration does not have sense of discomfort again; And do not have recurrence in 1 year, reach the purpose of radical cure.In clinical use, also do not find invalid case.
Technology contents of the present invention and technical characterstic the sixth of the twelve Earthly Branches disclose as above, yet the personage who is familiar with this technology still can do various replacement and the modifications that spirit is invented in this case that do not deviate from based on announcement of the present invention.Therefore, protection scope of the present invention should be not limited to embodiment announcement person, and should comprise various do not deviate from replacement of the present invention and modifications, and is contained by following claim.
Claims (2)
1. a tincture of treating verruca plana is characterized in that, the constituent of this tincture is that Mylabris, Flos Carthami and ethanol mass fraction are 75% ethanol; Wherein, the mass fraction of the Mylabris in this tincture is 2-30%, and the mass fraction of Flos Carthami is 10%-80%, and the ethanol mass fraction is that the mass fraction of 75% ethanol is 18-88%.
2. a manufacturing approach of treating the tincture of verruca plana is characterized in that, with Mylabris, Flos Carthami put into the ethanol mass fraction be 75% alcohol-pickled; Wherein the mass fraction of employed Mylabris is 2-30%, and the mass fraction of Flos Carthami is 10%-80%, and the ethanol mass fraction is that the mass fraction of 75% ethanol is 18-88%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100844767A CN101549002B (en) | 2009-05-19 | 2009-05-19 | Tincture for curing flat wart and method for preparing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100844767A CN101549002B (en) | 2009-05-19 | 2009-05-19 | Tincture for curing flat wart and method for preparing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101549002A CN101549002A (en) | 2009-10-07 |
| CN101549002B true CN101549002B (en) | 2012-01-25 |
Family
ID=41153645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100844767A Active CN101549002B (en) | 2009-05-19 | 2009-05-19 | Tincture for curing flat wart and method for preparing the same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101549002B (en) |
-
2009
- 2009-05-19 CN CN2009100844767A patent/CN101549002B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101549002A (en) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN101347559A (en) | Medicament for treating ulcer of skin | |
| CN102764353A (en) | Externally applied paste for treating furunculous trauma infection | |
| CN102406698B (en) | External medicinal liquid for treating vitiligo | |
| CN102596180A (en) | Anti-viral composition and method | |
| CN103446227A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN101829182B (en) | Medicament for treating prostatic diseases | |
| CN101549002B (en) | Tincture for curing flat wart and method for preparing the same | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN102228642B (en) | Ointment for external use for treating verruca plana | |
| CN103127473A (en) | Pain-relieving paste | |
| CN1107506C (en) | Medicine for treating tinea | |
| CN109078034A (en) | A kind of drug for treating canker sore | |
| CN103623007B (en) | A kind of external-applied ointment and preparation and application thereof for the treatment of the ringworm of scalp | |
| CN2673435Y (en) | Bio ear shield | |
| CN106138124A (en) | The new purposes method of Flos abelmoschi manihot total flavones treatment gynaecopathia (vaginitis, cervicitis, cervical erosion) | |
| CN1228064C (en) | Externally appied medicine for relieving pain and diminishing inflammation | |
| CN101596297B (en) | Tinea-curing pill | |
| CN102078538A (en) | Chinese medicine preparation for treating verruca plana | |
| CN101564498B (en) | External traditional Chinese medicine composition for curing mumps | |
| CN101352463B (en) | Plaster for treating parotiditis | |
| CN112494548A (en) | Plaster for promoting qi circulation and activating blood circulation and preparation method thereof | |
| CN101912398B (en) | Medicament for treating urinary tract infection | |
| CN1134263C (en) | Liniment for repairing scratched face without residual scar | |
| CN102920776A (en) | Medicine for treating wound infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |